A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis

NCT05604261 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Reflux Esophagitis
Gastroesophageal Reflux
Esophagitis
Esophageal Motility Disorders
Deglutition Disorders
Esophageal Diseases
Gastrointestinal Diseases

Interventions

DRUG: Anaprazole sodium 40 mg
DRUG: Anaprazole sodium 60 mg
DRUG: Rabeprazole sodium 20 mg

Sponsor

Xuanzhu Biopharmaceutical Co., Ltd.